Join the club for FREE to access the whole archive and other member benefits.

Curie.Bio

Biotech firm accelerating discovery of next generation human medicines

Curie.Bio is a new model for venture capital in biotech focused on helping founders launch serious therapeutics companies. The company is a unique combination of two businesses: we act as both your drug discovery copilot & seed investor.

Curie.Bio does this by giving founders access to a team of the world’s best drug hunters and drug makers, seed capital, and best-of-breed services - everything a founder needs to get from concept to a compelling quality dataset that enables an awesome Series A financing.

Visit website: https://curie.bio/

 curie-bio

 Curi_Bio

Details last updated 14-Nov-2023

Curie.Bio News

Forward therapeutics secures $50m to develop next-gen small molecule immune therapies

Forward therapeutics secures $50m to develop next-gen small molecule immune therapies

Longevity Technology - 09-Nov-2023

Company's pipeline targets inflammation, promote healing, and restore quality of life